Get started
Author

Peter‐Martin Bruch

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels
2020 · Tobias Roider, Julian Seufert, et al. · Nature Cell Biology · 176
PDF
Quantification of Differential Transcription Factor Activity and Multiomics-Based Classification into Activators and Repressors: diffTF
2019 · Ivan Berest, Christian Arnold, et al. · Cell Reports · 118
PDF
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
2022 · Maike Janssen, Christina Schmidt, et al. · Blood · 102
PDF
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
2021 · Nora Liebers, Claudius Speer, et al. · Blood · 86
PDF
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities
2024 · Tobias Roider, Marc A. Baertsch, et al. · Nature Cell Biology · 76
PDF
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia
2021 · Junyan Lu, Ester Cannizzaro, et al. · Nature Cancer · 64
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
2024 · Guido Kobbe, Monika Brüggemann, et al. · New England Journal of Medicine · 53
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
2022 · Sophie A. Herbst, Mattias Vesterlund, et al. · Nature Communications · 46
PDF
Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics
2024 · Aleix Rius Rigau, Yi-Nan Li, et al. · Circulation Research · 44
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial
2023 · Nora Liebers, Peter-Martin Bruch, et al. · Nature Cancer · 44
PDF
Functional analysis of structural variants in single cells using Strand-seq
2022 · Hyobin Jeong, Karen Grimes, et al. · Nature Biotechnology · 37
PDF
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
2026 · Christina Düsing, Andrea-Hermina Györfi, et al. · Nature Medicine · 32
PDF
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target
2025 · L. Llaó-Cid, JKL Wong, et al. · Nature Communications · 27
PDF
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models
2024 · Berit J. Brinkmann, Alessia Floerchinger, et al. · Blood · 20
Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
2022 · Peter‐Martin Bruch, Holly AR Giles, et al. · Molecular Systems Biology · 19
PDF
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)
2024 · Laura Schmitt, Julia Hoppe, et al. · Cell Death Discovery · 15
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
2022 · Peter-Martin Bruch, Sascha Dietrich, et al. · Leukemia · 14
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies
2023 · Sophie A. Herbst, Vladislav Kim, et al. · Blood Advances · 11
PDF
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
2021 · Selcen Öztürk, Yashna Paul, et al. · Leukemia · 10
PDF
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
2026 · Martin Dreyling, Martin Dreyling, et al. · The Lancet · 9
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia
2024 · Philipp M. Roessner, Isabelle Seufert, et al. · Blood · 6
A single-cell multi-omic and spatial atlas of B-cell lymphomas reveals differentiation drives intratumor heterogeneity
2023 · Donnacha Fitzgerald, Tobias Roider, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target
2022 · L Llaó Cid, JKL Wong, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
2026 · Felix Czernilofsky, Anna Mathioudaki, et al. · Nature Cancer · 5
Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL
2026 · Paul Marcoux, Fabien Gava, et al. · Blood · 4
Works count: 52
Citation count: 1,054
H-index: 15
I10-index: 19
Year
Topic
Type